Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blocking the FGF/FGFR system as a ⿿two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
Arianna Giacomini, Paola Chiodelli, Sara Matarazzo, et al.
Pharmacological Research (2016) Vol. 107, pp. 172-185
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Muthu K. Shanmugam, Sudha Warrier, Alan Prem Kumar, et al.
Current Vascular Pharmacology (2017) Vol. 15, Iss. 6
Closed Access | Times Cited: 192
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Marco Presta, Paola Chiodelli, Arianna Giacomini, et al.
Pharmacology & Therapeutics (2017) Vol. 179, pp. 171-187
Closed Access | Times Cited: 183
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 98
Tumor angiogenesis revisited: Regulators and clinical implications
Roberto Ronca, Mohammed Benkheil, Stefania Mitola, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1231-1274
Closed Access | Times Cited: 171
The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder
Robert Roskoski
Pharmacological Research (2019) Vol. 151, pp. 104567-104567
Closed Access | Times Cited: 116
Antiangiogenic Effect of Flavonoids and Chalcones: An Update
Ladislav Mirossay, Lenka Varinská, Ján Mojžíš
International Journal of Molecular Sciences (2017) Vol. 19, Iss. 1, pp. 27-27
Open Access | Times Cited: 106
Future applications of FGF/FGFR inhibitors in cancer
Gaia C. Ghedini, Roberto Ronca, Marco Presta, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 9, pp. 861-872
Closed Access | Times Cited: 89
FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells
Tao Jia, Thibault Jacquet, Fabien Dalonneau, et al.
BMC Biology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 87
The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
Maria Francesca Santolla, Marcello Maggiolini
Cancers (2020) Vol. 12, Iss. 10, pp. 3029-3029
Open Access | Times Cited: 82
Nano-targeting vascular remodeling in cancer: Recent developments and future directions
Roberta Giordo, Zena Wehbe, Panagiotis Paliogiannis, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 784-804
Open Access | Times Cited: 41
Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
Alessio Ardizzone, Valentina Bova, Giovanna Casili, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1002-1002
Open Access | Times Cited: 32
Long pentraxin 3: A novel multifaceted player in cancer
Arianna Giacomini, Gaia C. Ghedini, Marco Presta, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1869, Iss. 1, pp. 53-63
Closed Access | Times Cited: 80
Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2
Marco Presta, Eleonora Foglio, Ander Churruca Schuind, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 66
A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing
Francesca Angiolini, Elisa Belloni, Marco Giordano, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 52
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
Roberto Ronca, Gaia C. Ghedini, Federica Maccarinelli, et al.
Cancer Research (2020) Vol. 80, Iss. 11, pp. 2340-2354
Open Access | Times Cited: 44
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
Navid Sobhani, Anna Ianza, Alberto D’Angelo, et al.
Cells (2018) Vol. 7, Iss. 7, pp. 76-76
Open Access | Times Cited: 42
Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis
Eva Andreuzzi, Alessandra Capuano, Evelina Poletto, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3686-3686
Open Access | Times Cited: 34
Antiangiogenic role of natural flavonoids and their molecular mechanism: an update
Gowtham Kumar Subbaraj, Santhosh Kumar Yasam, Langeswaran Kulanthaivel
The Egyptian Journal of Internal Medicine (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 31
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis
Yan-Ran Bi, Ruiling Zheng, Jiahao Hu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 479-494
Open Access | Times Cited: 12
The fibroblast growth factor system in cognitive disorders and dementia
Wujianwen Zhai, Tong Zhang, Yujing Jin, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)
Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
Angiogenesis (2018) Vol. 22, Iss. 1, pp. 133-144
Closed Access | Times Cited: 38
Retinoic acid signaling in vascular development
Bradley Pawlikowski, Jacob Wragge, Julie A. Siegenthaler
genesis (2019) Vol. 57, Iss. 7-8
Open Access | Times Cited: 34
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
Arianna Giacomini, Sara Taranto, Sara Rezzola, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9376-9376
Open Access | Times Cited: 31
Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
Valery A. Petrenko, James W. Gillespie, Laura M. De Plano, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 384-384
Open Access | Times Cited: 19
FGFR-targeted therapeutics for the treatment of breast cancer
Antonella De Luca, Daniela Frezzetti, Marianna Gallo, et al.
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 3, pp. 303-311
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top